- Report
- October 2024
- 193 Pages
Global
From €3235EUR$3,545USD£2,759GBP
€3595EUR$3,939USD£3,065GBP
- Report
- August 2024
- 100 Pages
Global
From €5430EUR$5,950USD£4,630GBP
- Report
- March 2025
- 200 Pages
Global
From €4098EUR$4,490USD£3,494GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €2738EUR$3,000USD£2,335GBP
- Clinical Trials
- December 2024
- 1389 Pages
Global
From €3149EUR$3,450USD£2,685GBP
- Report
- April 2025
- 193 Pages
Global
From €5339EUR$5,850USD£4,552GBP
- Report
- July 2024
- 136 Pages
Global
From €2737EUR$2,999USD£2,334GBP
- Report
- May 2024
- 139 Pages
Global
From €5931EUR$6,499USD£5,057GBP
- Report
- September 2022
- 232 Pages
Global
From €3194EUR$3,500USD£2,724GBP
- Report
- January 2022
- 60 Pages
Global
From €3605EUR$3,950USD£3,074GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2738EUR$3,000USD£2,335GBP
- Report
- March 2024
- 150 Pages
Global
From €4061EUR$4,450USD£3,463GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4517EUR$4,950USD£3,852GBP
- Report
- November 2023
- 181 Pages
Global
From €4107EUR$4,500USD£3,502GBP
- Report
- August 2023
- 47 Pages
Global
From €3646EUR$3,995USD£3,109GBP
- Report
- September 2020
- 47 Pages
Global
From €3646EUR$3,995USD£3,109GBP
- Drug Pipelines
- August 2020
- 693 Pages
Global
From €1825EUR$2,000USD£1,556GBP
- Report
- August 2022
United States
From €1770EUR$1,940USD£1,510GBP
- Report
- August 2022
Global
From €995EUR$1,090USD£848GBP
- Report
- August 2021
Global
From €3641EUR$3,990USD£3,105GBP

Crohn Disease is a chronic inflammatory disorder of the gastrointestinal tract, and is one of the most common immune disorders. Treatment for Crohn Disease typically involves a combination of medications, lifestyle changes, and in some cases, surgery. Common medications used to treat Crohn Disease include corticosteroids, immunomodulators, biologic therapies, and antibiotics. Corticosteroids are used to reduce inflammation, while immunomodulators are used to suppress the immune system. Biologic therapies are used to target specific proteins in the body that are involved in the inflammatory process, and antibiotics are used to treat bacterial infections.
The Crohn Disease Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of Crohn Disease, as well as the development of new and innovative treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Pfizer, and UCB. Show Less Read more